Pancreatic cancer action network - Join us
Clinical Trial
Finder
Retrieving Trials
Retrieving Trials...

Back to Trial Search

Phase I Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®18087 in Patients with Advanced Neuroendocrine and Gastrointestinal Stromal Tumors

Summary

The purpose of this phase I study is to evaluate the safety and tolerability and establish a recommended dose of XmAb18087 in patients with advanced NET or GIST.

General Information

NCT#: NCT03411915
Study ID: XmAb18087-01
Trial Phase: Phase I

Trial Sponsor: Xencor, Inc.
Therapies Used in This Trial: XmAb18087

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account?

Request an Account


  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account.
  • In order to view this information, you need to be signed in as a Health Care Provider.
  • In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
  • This information is restricted to validated Health Care Providers.

Eligibility



-------------------------------------------------------------------------------------------

  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
  • ------------------------------------------------------------------------------------------------------
  • In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information


Back to Trial Search